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Introduction
This study analysed the outcome of patients undergoing
surgery for T1–T2 oral squamous cell carcinoma (OSCC)
in order to identify the prognostic value of several clinical
characteristics.
Materials and methods
A total of 115 patients were studied who had undergone
surgery for OSCC between 1992 and 2001, of which 25
had received postoperative radiotherapy.
For each patient, personal data, age at first OSCC, histo-
logical findings, treatment, and outcome were recorded
and analysed statistically. Survival curves were calculated
using the Kaplan-Meier algorithm, and the difference in
survival among subgroups was examined.
Results
The overall 5-year survival rate in the 115 patients was
82%. Clinical, operative and pathological parameters
including recurrence, site of origin, vascular, perineural
and osseous involvement and length of surgery as dis-
criminators were found to affect survival at 5 years.
Conclusion
The overall survival rate was within the (previously)
reported range. The prognostic value of many parameters
is widely recognized; the combined evaluation of 'com-
posite factors' might uncover other clinical characteristics
which might affect the survival in this group of patients.
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